Procaine treatments for cognition and dementia

Balaceanu Stolnici, 1989, Gerovital h3 effects upon human cognitive behaviour and psychomotor capacity, Romanian Journal of Gerontology and Geriatrics, 10, 277

Cashman, 1961, A controlled trial of "Gerioptil", BMJ, 1, 554, 10.1136/bmj.1.5225.554

Hall, 1983, The effects of procaine/haematoporphyrin on age-related decline: a double-blind trial, Age and Ageing, 12, 302, 10.1093/ageing/12.4.302

The Southampton Ageing Project The Southampton Ageing Project: A trial of KH3 The Southampton Ageing Project 1982

Abrams, 1965, The effects of a European procaine preparation in an aged population, Journal of Gerontology, 20, 139, 10.1093/geronj/20.2.139

Aslan, 1956, A new method for prophylaxis and treatment of aging with novocain-eutrophic and rejuvenating effects, Therapiewoche, 7, 14

Aslan, 1980, Aslavital for children in mentally deficient subjects, Romanian Journal of Gerontology and Geriatrics, 1, 189

Aslan, 1980, The aslavital treatment in the recovery of mentally-deficient children, Romanian Journal of Gerontology and Geriatrics, 1, 93

Berryman, 1961, Trial of procaine in old age and chronic degenerative disorders, BMJ, 2, 1683, 10.1136/bmj.2.5268.1683

Czerwenka, 1970, Clinical and psychological investigations with a geriatric substance (in German), Wiener Medizinische Wochenschrift, 120, 217

Fee, 1961, Trial of procaine in the aged, BMJ, 2, 1680, 10.1136/bmj.2.5268.1680

Gericke, 1961, An evaluation of procaine in geriatric patients in a mental hospital, Journal of Clinical and Experimental Psychopathology, 22, 18

Hirsch, 1961, A clinical trial of procaine hydrochloride, BMJ, 2, 1684, 10.1136/bmj.2.5268.1684

Isaacs, 1962, Trials of procaine in aged patients, BMJ, 2, 188, 10.1136/bmj.1.5272.188-a

Kant, 1962, Evaluation of chronically ill patients treated for one year with procaine, Journal of the American Geriatrics Society, 10, 408, 10.1111/j.1532-5415.1962.tb00313.x

Kent, 1982, The procaine "youth" drugs, Geriatrics, 37, 32

Long, 1964, The effect of procaine on orientation, attention, memory and weight of aged psychiatric patients, Journal of Neuropsychiatry, 5, 186

May, 1962, Prolonged procaine therapy in geriatric psychiatric patients, Geriatrics, 17, 161

Olsen, 1978, Gerovital-H3: a clinical trial as an antidepressant, Journal of Gerontology, 33, 514, 10.1093/geronj/33.4.514

Ostfeld, 1977, The systemic use of procaine in the treatment of the elderly: a review, Journal of the American Geriatrics Society, 5, 1, 10.1111/j.1532-5415.1977.tb00917.x

Quatember, 1980, Neuropsychological methods of examination of age-specific performance parameters, Wiener Medizinische Wochenschrift, 130, 688

Rusu, 1996, Antioxidant and lipid-lowering effects of the original procaine-based products, Romanian Journal of Gerontology and Geriatrics, 18, 47

Sakalis, 1974, A trial of gerovital H-3 in depression during senility, Current Therapeutic Research, Clinical and Experimental, 16, 59

Smigel, 1960, H-3 (procaine hydrochloride) therapy in aging institutionalized patients: an interim report, Journal of the American Geriatrics Society, 8, 785, 10.1111/j.1532-5415.1960.tb00094.x

Valtonen, 1992, Procaine chloride as a universal remedy for somatic and psychic symptoms, Suomen Lookorilehti, 47, 1608

Zdichynec, 1977, Successes in novocain therapy in the control of premature ageing, Z Alternsforsch, 32, 267

Zwerling, 1975, Effects of a procaine preparation (Gerovital H3) in hospitalized geriatric patients: a double-blind study, Journal of the American Geriatrics Society, 23, 355, 10.1111/j.1532-5415.1975.tb00326.x

American Psychiatric Association, 1987, Diagnostic and Statistical Manual of Mental Disorders

American Psychiartric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. Vol IV

Automatic detention alert for Gerovital http://www.fda.gov/ora/fiars/ora_import_ia6101.html

http://www.gh3.co.uk/

Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008] Available from www.cochrane-handbook.org

McKhann, 1984, Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 4, 939, 10.1212/WNL.34.7.939

Román, 1993, Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250

Development of Ultimate 9 http://www.achilleshealthmart.com/vitacel_koch.htm

World Health Organisation, 1992, International classification of diseases, 10th revision